{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-042062","form_type":"8-K","ticker":"AIMD","cik":"0001014763","company_name":"Ainos, Inc.","filed_at":"2024-10-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.374172+00:00","generated_at":"2026-05-30T11:23:23.386963+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ainos adds exclusive patent rights and co-development of nitrogen-oxygen separation machine with TCNT","bullets":["Third Addendum to Product Development Agreement adds nitrogen-oxygen separation machine for medical oxygen and wound healing.","TCNT grants Ainos exclusive sales rights and full patent authorization for the new machine.","Exclusive patent use fee set at $50,000/month plus 5% sales tax for one year starting October 16, 2024.","TCNT controls ~62.9% of Ainos voting power as of October 17, 2024.","Co-development scope expanded to include VELDONA drug pre-processing and manufacturing development."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-042062","json":"https://secwatch.observer/filing/0001493152-24-042062.json","markdown":"https://secwatch.observer/filing/0001493152-24-042062.md","text":"https://secwatch.observer/filing/0001493152-24-042062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1014763/000149315224042062/0001493152-24-042062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1014763/000149315224042062/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T11:23:23.386963+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}